Estonian Deeptech Startup SafePAS Raises €700k to Disrupt €14B Drug Testing Market

SafePAS, an Estonian deeptech startup transforming the future of drug detection, has raised €700,000 in a pre-seed round led by BSV Ventures, with participation from Prague-based PurposeTech, EstBAN or Beamline. The investment will fast-track the commercialization of Drug Hunter—SafePAS’ flagship handheld device for quantitative, rapid drug testing.